Epidemiology of left ventricular hypertrophy in hypertension: implications for the clinic

References

• Koren MJ, Devereux RB, Casale PN, et al. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991;114:345–352.
   PubMed Web of Science ®Google Scholar
• Levy D, Garrison RJ, Savage DD, et al. Prognostic implications of echocardiographically determined left ventricular mass in the framingham heart study. N Engl J Med. 1990;322:1561–1566.
   PubMed Web of Science ®Google Scholar
• Marwick TH, Gillebert TC, Aurigemma G, et al. Recommendations on the use of echocardiography in adult hypertension: a report from the European Association of Cardiovascular Imaging (EACVI) and the American Society of Echocardiography (ASE)dagger. Eur Heart J Cardiovasc Imaging. 2015;16:577–605.
   PubMed Web of Science ®Google Scholar
• Lund BP, Gohlke-Barwolf C, Cramariuc D, et al. Effect of obesity on left ventricular mass and systolic function in patients with asymptomatic aortic stenosis (a Simvastatin Ezetimibe in Aortic Stenosis [SEAS] substudy). Am J Cardiol. 2010;105:1456–1460.
   PubMed Web of Science ®Google Scholar
• Roman MJ, Ganau A, Saba PS, et al. Left ventricular hypertrophy, arterial compliance, and aging. Adv Exp Med Biol. 1997;432:13–22.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Wachtell K, Gerdts E, et al. Prognostic significance of left ventricular mass change during treatment of hypertension. JAMA. 2004;292:2350–2356.
   PubMed Web of Science ®Google Scholar
• Gerdts E, Rossebo AB, Pedersen TR, et al. Relation of left ventricular mass to prognosis in initially asymptomatic mild to moderate aortic valve stenosis. Circ Cardiovasc Imaging. 2015;8:e003644.
   PubMed Web of Science ®Google Scholar
• Bang CN, Gerdts E, Aurigemma GP, et al. Four-group classification of left ventricular hypertrophy based on ventricular concentricity and dilatation identifies a low-risk subset of eccentric hypertrophy in hypertensive patients. Circ Cardiovasc Imaging. 2014;7:422–429.
   PubMed Web of Science ®Google Scholar
• Khouri MG, Peshock RM, Ayers CR, et al. A 4-tiered classification of left ventricular hypertrophy based on left ventricular geometry: the dallas heart study. Circ Cardiovasc Imaging. 2010;3:164–171.
   PubMed Web of Science ®Google Scholar
• Devereux RB, de Simone G, Ganau A, et al. Left ventricular hypertrophy and geometric remodeling in hypertension: stimuli, functional consequences and prognostic implications. J Hypertens Suppl. 1994;12:S117–S127.
   Google Scholar
• Aurigemma GP, Silver KH, Priest MA, et al. Geometric changes allow normal ejection fraction despite depressed myocardial shortening in hypertensive left ventricular hypertrophy. J Am Coll Cardiol. 1995;26:195–202.
   PubMed Web of Science ®Google Scholar
• Gerdts E, Zabalgoitia M, Bjornstad H, et al. Gender differences in systolic left ventricular function in hypertensive patients with electrocardiographic left ventricular hypertrophy (the LIFE study). Am J Cardiol. 2001;87:980–983.
   PubMed Web of Science ®Google Scholar
• Gerdts E, Okin PM, de Simone G, et al. Gender differences in left ventricular structure and function during antihypertensive treatment: the losartan intervention for endpoint reduction in hypertension study. Hypertension. 2008;51:1109–1114.
   PubMed Web of Science ®Google Scholar
• Tuseth N, Cramariuc D, Rieck AE, et al. Asymmetric septal hypertrophy - a marker of hypertension in aortic stenosis (a SEAS substudy). Blood Press. 2010;19:140–144.
   PubMed Web of Science ®Google Scholar
• Diamond JA, Phillips RA. Hypertensive heart disease. Hypertens Res. 2005;28:191–202.
   PubMed Web of Science ®Google Scholar
• Briet M, Barhoumi T, Mian MO, et al. Aldosterone-induced vascular remodeling and endothelial dysfunction require functional angiotensin type 1a receptors. Hypertension. 2016;67:897–905.
   PubMed Web of Science ®Google Scholar
• Cacciapuoti F. Molecular mechanisms of left ventricular hypertrophy (LVH) in systemic hypertension (SH)-possible therapeutic perspectives. J Am Soc Hypertens. 2011;5:449–455.
   PubMed Web of Science ®Google Scholar
• Burnier M, Forni V. Endothelin receptor antagonists: a place in the management of essential hypertension? Nephrol Dial Transplant. 2012;27:865–868.
   PubMed Web of Science ®Google Scholar
• Uehata M, Ishizaki T, Satoh H, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 1997;389:990–994.
   PubMed Web of Science ®Google Scholar
• Lynch AI, Tang W, Shi G, et al. Epistatic effects of ACE I/D and AGT gene variants on left ventricular mass in hypertensive patients: the HyperGEN study. J Hum Hypertens. 2012;26:133–140.
   PubMed Web of Science ®Google Scholar
• Da Costa Martins PA, De Windt LJ. MicroRNAs in control of cardiac hypertrophy. Cardiovasc Res. 2012;93:563–572.
   PubMed Web of Science ®Google Scholar
• Queiros AM, Eschen C, Fliegner D, et al. Sex- and estrogen-dependent regulation of a miRNA network in the healthy and hypertrophied heart. Int J Cardiol. 2013;169:331338.
   Web of Science ®Google Scholar
• Galderisi M, Capaldo B, Sidiropulos M, et al. Determinants of reduction of coronary flow reserve in patients with type 2 diabetes mellitus or arterial hypertension without angiographically determined epicardial coronary stenosis. Am J Hypertens. 2007;20:1283–1290.
   PubMed Web of Science ®Google Scholar
• Lonnebakken MT, Rieck AE, Gerdts E. Contrast stress echocardiography in hypertensive heart disease. Cardiovasc Ultrasound. 2011;9:33. doi:10.1186/14767120-9-33.
   PubMed Web of Science ®Google Scholar
• Kato S, Saito N, Kirigaya H, et al. Impairment of coronary flow reserve evaluated by phase contrast cine-magnetic resonance imaging in patients with heart failure with preserved ejection fraction. J Am Heart Assoc. 2016;5:pii: e002649. doi:10.1161/JAHA.115.002649.
   PubMed Web of Science ®Google Scholar
• Eskerud I, Gerdts E, Nordrehaug JE, et al. Global coronary artery plaque area is associated with myocardial hypoperfusion in women with non-ST elevation myocardial infarction. J Womens Health (Larchmt). 2015;24:367–373.
   PubMed Web of Science ®Google Scholar
• de Simone G, Izzo R, De Luca N, et al. Left ventricular geometry in obesity: Is it what we expect? Nutr Metab Cardiovasc Dis. 2013;23:905–912.
   PubMed Web of Science ®Google Scholar
• Bella JN, Devereux RB, Roman MJ, et al. Relations of left ventricular mass to fat-free and adipose body mass: the strong heart study. The strong heart study investigators. Circulation. 1998;98:2538–2544.
   PubMed Web of Science ®Google Scholar
• Pelliccia A, Maron MS, Maron BJ. Assessment of left ventricular hypertrophy in a trained athlete: differential diagnosis of physiologic athlete’s heart from pathologic hypertrophy. Prog Cardiovasc Dis. 2012;54:387–396.
   PubMed Web of Science ®Google Scholar
• Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2733–2779.
   PubMed Web of Science ®Google Scholar
• Smid BE, van der Tol L, Cecchi F, et al. Uncertain diagnosis of Fabry disease: consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance. Int J Cardiol. 2014;177:400–408.
   PubMed Web of Science ®Google Scholar
• Lin FY, Devereux RB, Roman MJ, et al. Cardiac chamber volumes, function, and mass as determined by 64-multidetector row computed tomography: mean values among healthy adults free of hypertension and obesity. JACC Cardiovasc Imaging. 2008;1:782–786.
   PubMed Web of Science ®Google Scholar
• Bacharova L, Chen H, Estes EH, et al. Determinants of discrepancies in detection and comparison of the prognostic significance of left ventricular hypertrophy by electrocardiogram and cardiac magnetic resonance imaging. Am J Cardiol. 2015;115:515–522.
   PubMed Web of Science ®Google Scholar
• Lehtonen AO, Puukka P, Varis J, et al. Prevalence and prognosis of ECG abnormalities in normotensive and hypertensive individuals. J Hypertens. 2016;34:959–966.
   PubMed Web of Science ®Google Scholar
• MacMahon S, Collins G, Rautaharju P, et al. Electrocardiographic left ventricular hypertrophy and effects of antihypertensive drug therapy in hypertensive participants in the multiple risk factor intervention trial. Am J Cardiol. 1989;63:202–210.
   PubMed Web of Science ®Google Scholar
• Kannel WB. Prevalence and natural history of electrocardiographic left ventricular hypertrophy. Am J Med. 1983;75:4–11.
   PubMed Web of Science ®Google Scholar
• Task Force for the management of arterial hypertension of the European Society of Hypertension; Task Force for the management of arterial hypertension of the European Society of Cardiology. 2013 ESH/ESC guidelines for the management of arterial hypertension. Blood Press. 2013;22:193–278.
   PubMed Web of Science ®Google Scholar
• Derosa G, Maffioli P. Assessment and management of left ventricular hypertrophy in type 2 diabetes patients with high blood pressure. Expert Rev Cardiovasc Ther. 2013;11:719–728.
   PubMedGoogle Scholar
• Bursztyn M, Leibowitz D, Stessman-Lande I, et al. Left ventricular mass as a risk factor in the oldest old. J Clin Hypertens (Greenwich). 2015;17:874–879.
   PubMed Web of Science ®Google Scholar
• Gerdts E, Cramariuc D, de Simone G, et al. Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). Eur J Echocardiogr. 2008;9:809–815.
   PubMed Web of Science ®Google Scholar
• Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American society of echocardiography and the European association of cardiovascular imaging. J Am Soc Echocardiogr. 2015;28:1–39.
   PubMed Web of Science ®Google Scholar
• de Simone G, Devereux RB, Izzo R, et al. Lack of reduction of left ventricular mass in treated hypertension: the strong heart study. J Am Heart Assoc. 2013;2(3):e000144.
   Google Scholar
• Chirinos JA, Segers P, De Buyzere ML, et al. Left ventricular mass: allometric scaling, normative values, effect of obesity, and prognostic performance. Hypertension. 2010;56:91–98.
   PubMed Web of Science ®Google Scholar
• Kannel WB. Left ventricular hypertrophy as a risk factor in arterial hypertension. Eur Heart J. 1992;13(Suppl D):82–88.
   PubMed Web of Science ®Google Scholar
• Estes EH, Zhang ZM, Li Y, et al. The Romhilt-Estes left ventricular hypertrophy score and its components predict all-cause mortality in the general population. Am Heart J. 2015;170:104–109.
   PubMed Web of Science ®Google Scholar
• Ghali JK, Liao Y, Simmons B, et al. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med. 1992;117:831–836.
   PubMed Web of Science ®Google Scholar
• Okin PM, Devereux RB, Jern S, et al. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA. 2004;292:2343–2349.
   PubMed Web of Science ®Google Scholar
• Okin PM, Oikarinen L, Viitasalo M, et al. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point reduction in hypertension study (LIFE). Circulation. 2009;119:1883–1891.
   PubMed Web of Science ®Google Scholar
• Gerdts E, Okin PM, Boman K, et al. Association of heart failure hospitalizations with combined electrocardiography and echocardiography criteria for left ventricular hypertrophy. Am J Hypertens. 2012;25:678–683.
   PubMed Web of Science ®Google Scholar
• Angeli F, Reboldi G, Poltronieri C, et al. The prognostic legacy of left ventricular hypertrophy: cumulative evidence after the MAVI study. J Hypertens. 2015;33:23222330.
   Web of Science ®Google Scholar
• Hancock EW, Deal BJ, Mirvis DM, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol. 2009;53:992–1002.
   PubMed Web of Science ®Google Scholar
• Hsieh BP, Pham MX, Froelicher VF. Prognostic value of electrocardiographic criteria for left ventricular hypertrophy. Am Heart J. 2005;150:161–167.
   PubMed Web of Science ®Google Scholar
• Okin PM, Roman MJ, Devereux RB, et al. Electrocardiographic identification of increased left ventricular mass by simple voltage-duration products. J Am Coll Cardiol. 1995;25:417–423.
   PubMed Web of Science ®Google Scholar
• Okin PM, Roman MJ, Devereux RB, et al. Electrocardiographic identification of left ventricular hypertrophy: test performance in relation to definition of hypertrophy and presence of obesity. J Am Coll Cardiol. 1996;27:124–131.
   PubMed Web of Science ®Google Scholar
• Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986;57:450458.
   Web of Science ®Google Scholar
• de Simone G, Kizer JR, Chinali M, et al. Normalization for body size and populationattributable risk of left ventricular hypertrophy: the strong heart study. Am J Hypertens. 2005;18:191–196.
   PubMed Web of Science ®Google Scholar
• Natori S, Lai S, Finn JP, et al. Cardiovascular function in multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity. Am J Roentgenol. 2006;186:S357–S365.
   PubMed Web of Science ®Google Scholar
• Stewart GA, Foster J, Cowan M, et al. Echocardiography overestimates left ventricular mass in hemodialysis patients relative to magnetic resonance imaging. Kidney Int. 1999;56:2248–2253.
   PubMed Web of Science ®Google Scholar
• Codella NC, Lee HY, Fieno DS, et al. Improved left ventricular mass quantification with partial voxel interpolation: in vivo and necropsy validation of a novel cardiac MRI segmentation algorithm. Circ Cardiovasc Imaging. 2012;5:137–146.
   PubMed Web of Science ®Google Scholar
• Neeland IJ, Drazner MH, Berry JD, et al. Biomarkers of chronic cardiac injury and hemodynamic stress identify a malignant phenotype of left ventricular hypertrophy in the general population. J Am Coll Cardiol. 2013;61:187–195.
   PubMed Web of Science ®Google Scholar
• Seliger SL, de LJ, Neeland IJ, et al. Older adults, “Malignant” left ventricular hypertrophy, and associated cardiac-specific biomarker phenotypes to identify the differential risk of new-onset reduced versus preserved ejection fraction heart failure: CHS (Cardiovascular Health Study). JACC Heart Fail. 2015;3:445–455.
   PubMed Web of Science ®Google Scholar
• de Simone G, Devereux RB. Rationale of echocardiographic assessment of left ventricular wall stress and midwall mechanics in hypertensive heart disease. Eur J Echocardiogr. 2002;3:192–198.
   PubMedGoogle Scholar
• Hein S, Arnon E, Kostin S, et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation. 2003;107:984–991.
   PubMed Web of Science ®Google Scholar
• de Simone G, Devereux RB, Koren MJ, et al. Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension. Circulation. 1996;93:259–265.
   PubMed Web of Science ®Google Scholar
• Cramariuc D, Cioffi G, Rieck AE, et al. Low-flow aortic stenosis in asymptomatic patients: valvular-arterial impedance and systolic function from the SEAS substudy. JACC Cardiovasc Imaging. 2009;2:390–399.
   PubMed Web of Science ®Google Scholar
• Cramariuc D, Rogge BP, Lonnebakken MT, et al. Sex differences in cardiovascular outcome during progression of aortic valve stenosis. Heart. 2015;101:209–214.
   PubMed Web of Science ®Google Scholar
• Cioffi G, Faggiano P, Lucci D, et al. Inappropriately high left ventricular mass in patients with type 2 diabetes mellitus and no overt cardiac disease. The DYDA study. J Hypertens. 2011;29:1994–2003.
   PubMed Web of Science ®Google Scholar
• Cioffi G, de Simone G, Cramariuc D, et al. Inappropriately high left-ventricular mass in asymptomatic mild-moderate aortic stenosis. J Hypertens. 2012;30:421–428.
   PubMed Web of Science ®Google Scholar
• Wachtell K, Olsen MH. Impaired left ventricular systolic function in patients with left ventricular hypertrophy. J Hypertens. 2011;29:2068–2069.
   PubMed Web of Science ®Google Scholar
• Villar AV, Llano M, Cobo M, et al. Gender differences of echocardiographic and gene expression patterns in human pressure overload left ventricular hypertrophy. J Mol Cell Cardiol. 2009;46:526–535.
   PubMed Web of Science ®Google Scholar
• Cioffi G, Rossi A, Targher G, et al. Usefulness of subclinical left ventricular midwall dysfunction to predict cardiovascular mortality in patients with type 2 diabetes mellitus. Am J Cardiol. 2014;113:1409–1414.
   PubMed Web of Science ®Google Scholar
• Stanton T, Leano R, Marwick TH. Prediction of all-cause mortality from global longitudinal speckle strain: comparison with ejection fraction and wall motion scoring. Circ Cardiovasc Imaging. 2009;2:356–364.
   PubMed Web of Science ®Google Scholar
• Russo C, Jin Z, Elkind MS, et al. Prevalence and prognostic value of subclinical left ventricular systolic dysfunction by global longitudinal strain in a community-based cohort. Eur J Heart Fail. 2014;16:1301–1309.
   PubMed Web of Science ®Google Scholar
• Kouzu H, Yuda S, Muranaka A, et al. Left ventricular hypertrophy causes different changes in longitudinal, radial, and circumferential mechanics in patients with hypertension: a two-dimensional speckle tracking study. J Am Soc Echocardiogr. 2011;24:192–199.
   PubMed Web of Science ®Google Scholar
• Cheng S, Shah AM, Albisu JP, et al. Reversibility of left ventricular mechanical dysfunction in patients with hypertensive heart disease. J Hypertens. 2014;32:24792486.
   Web of Science ®Google Scholar
• Cramariuc D, Gerdts E, Davidsen ES, et al. Myocardial deformation in aortic valve stenosis: relation to left ventricular geometry. Heart. 2010;96:106–112.
   PubMed Web of Science ®Google Scholar
• Hoffmann R, Altiok E, Friedman Z, et al. Myocardial deformation imaging by twodimensional speckle-tracking echocardiography in comparison to late gadolinium enhancement cardiac magnetic resonance for analysis of myocardial fibrosis in severe aortic stenosis. Am J Cardiol. 2014;114:1083–1088.
   PubMed Web of Science ®Google Scholar
• Goodman A, Kusunose K, Popovic ZB, et al. Synergistic utility of brain natriuretic peptide and left ventricular strain in patients with significant aortic stenosis. J Am Heart Assoc. 2016;5:pii: e002561. doi:10.1161/JAHA.115.002561.
   PubMed Web of Science ®Google Scholar
• Celic V, Tadic M, Suzic-Lazic J, et al. Two- and three-dimensional speckle tracking analysis of the relation between myocardial deformation and functional capacity in patients with systemic hypertension. Am J Cardiol. 2014;113:832–839.
   PubMed Web of Science ®Google Scholar
• Henein M, Morner S, Lindmark K, et al. Impaired left ventricular systolic function reserve limits cardiac output and exercise capacity in HFpEF patients due to systemic hypertension. Int J Cardiol. 2013;168:1088–1093.
   PubMed Web of Science ®Google Scholar
• Cramariuc D, Gerdts E, Hjertaas JJ, et al. Myocardial function in aortic stenosis-insights from radial multilayer doppler strain. Cardiovasc Ultrasound. 2015;13:8. doi:10.1186/s12947-015-0001-z.
   PubMed Web of Science ®Google Scholar
• Saeki M, Sato N, Kawasaki M, et al. Left ventricular layer function in hypertension assessed by myocardial strain rate using novel one-beat real-time three-dimensional speckle tracking echocardiography with high volume rates. Hypertens Res. 2015;38:551–559.
   PubMed Web of Science ®Google Scholar
• Gerdts E, Oikarinen L, Palmieri V, et al. Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. Hypertension. 2002;39:739–743.
   PubMed Web of Science ®Google Scholar
• Gerdts E, Wachtell K, Omvik P, et al. Left atrial size and risk of major cardiovascular events during antihypertensive treatment: losartan intervention for endpoint reduction in hypertension trial. Hypertension. 2007;49:311–316.
   PubMed Web of Science ®Google Scholar
• Tsang TS, Barnes ME, Bailey KR, et al. Left atrial volume: important risk marker of incident atrial fibrillation in 1655 older men and women. Mayo Clin Proc. 2001;76:467–475.
   PubMed Web of Science ®Google Scholar
• Yaghi S, Moon YP, Mora-McLaughlin C, et al. Left atrial enlargement and stroke recurrence: the northern manhattan stroke study. Stroke. 2015;46:1488–1493.
   PubMed Web of Science ®Google Scholar
• Russo C, Jin Z, Liu R, et al. LA volumes and reservoir function are associated with subclinical cerebrovascular disease: the CABL (Cardiovascular Abnormalities and Brain Lesions) study. JACC Cardiovasc Imaging. 2013;6:313–323.
   PubMed Web of Science ®Google Scholar
• Chinali M, de SG, Wachtell K, et al. Left atrial systolic force in hypertensive patients with left ventricular hypertrophy: the LIFE study. J Hypertens. 2008;26:1472–1476.
   PubMed Web of Science ®Google Scholar
• Wachtell K, Smith G, Gerdts E, et al. Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan intervention for endpoint. Am J Cardiol. 2000;85:466–472.
   PubMed Web of Science ®Google Scholar
• Wachtell K, Palmieri V, Gerdts E, et al. Prognostic significance of left ventricular diastolic dysfunction in patients with left ventricular hypertrophy and systemic hypertension (the LIFE study). Am J Cardiol. 2010;106:999–1005.
   PubMed Web of Science ®Google Scholar
• Dahl JS, Christensen NL, Videbaek L, et al. Left ventricular diastolic function is associated with symptom status in severe aortic valve stenosis. Circ Cardiovasc Imaging. 2014;7:142–148.
   PubMed Web of Science ®Google Scholar
• Wachtell K, Bella JN, Rokkedal J, et al. Change in diastolic left ventricular filling after one year of antihypertensive treatment: the Losartan Intervention For Endpoint reduction in hypertension (LIFE) study. Circulation. 2002;105:1071–1076.
   PubMed Web of Science ®Google Scholar
• Sharp AS, Tapp RJ, Thom SA, et al. Tissue Doppler E/E’ ratio is a powerful predictor of primary cardiac events in a hypertensive population: an ASCOT substudy. Eur Heart J. 2010;31:747–752.
   PubMed Web of Science ®Google Scholar
• Wang M, Yip GW, Wang AY, et al. Tissue Doppler imaging provides incremental prognostic value in patients with systemic hypertension and left ventricular hypertrophy. J Hypertens. 2005;23:183–191.
   PubMed Web of Science ®Google Scholar
• Kuruvilla S, Janardhanan R, Antkowiak P, et al. Increased extracellular volume and altered mechanics are associated with LVH in hypertensive heart disease, not hypertension alone. JACC Cardiovasc Imaging. 2015;8:172–180.
   PubMed Web of Science ®Google Scholar
• Goebel B, Gjesdal O, Kottke D, et al. Detection of irregular patterns of myocardial contraction in patients with hypertensive heart disease: a two-dimensional ultrasound speckle tracking study. J Hypertens. 2011;29:2255–2264.
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Bavishi C, Sardar P, et al. Meta-analysis of left ventricular hypertrophy and sustained arrhythmias. Am J Cardiol. 2014;114:1049–1052.
   PubMed Web of Science ®Google Scholar
• Wachtell K, Devereux RB, Harris KE, et al. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. JAMA. 2006;296:1242–1248.
   PubMed Web of Science ®Google Scholar
• Chrispin J, Jain A, Soliman EZ, et al. Association of electrocardiographic and imaging surrogates of left ventricular hypertrophy with incident atrial fibrillation: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol. 2014;63:2007–2013.
   PubMed Web of Science ®Google Scholar
• Proietti M, Marra AM, Tassone EJ, et al. Frequency of left ventricular hypertrophy in non-valvular atrial fibrillation. Am J Cardiol. 2015;116:877–882.
   PubMed Web of Science ®Google Scholar
• Pitt B, Reichek N, Willenbrock R, et al. Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study. Circulation. 2003;108:18311838.
   Web of Science ®Google Scholar
• Schmieder RE, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. Jama. 1996;275:1507–1513.
   PubMed Web of Science ®Google Scholar
• Parving HH, Brenner BM, McMurray JJ, et al. Cardiorenal end points in a trial of aliskiren for type 2 diabetes. N Engl J Med. 2012;367:2204–2213.
   PubMed Web of Science ®Google Scholar
• Yusuf S, Teo KK, Pogue J, et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med. 2008;358:1547–1559.
   PubMed Web of Science ®Google Scholar
• Gerdts E, de Simone G, Lund BP, et al. Impact of overweight and obesity on cardiac benefit of antihypertensive treatment. Nutr Metab Cardiovasc Dis. 2013;23:122–129.
   PubMed Web of Science ®Google Scholar